group_id,Component_26,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00531,0.5985439090524904,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_06154,0.5309320626022579,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_05071,0.5010233118435568,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_09826,0.4630676924017893,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_07911,0.4516553255552587,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_08098,0.4163472049448897,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_07144,0.413577471397088,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_09596,0.4125214448462795,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09443,0.4048872491167559,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_03099,0.4013142541648396,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_08849,0.398988630011131,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02532,0.3938321628793073,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_04999,0.3882617473823333,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09295,0.3832736081798914,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_00242,0.3812477735133789,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_05136,0.3778513575503557,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_09091,0.3708584981434511,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_01995,0.369260321316704,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_05654,0.3667825402537962,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_01483,0.3653721922685227,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_07229,0.3565136329832595,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_04538,0.355656304305437,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_00511,0.3536035178653016,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_08217,0.352349751609298,FUN_036077-T1,Peve_00018989,Pocillopora_meandrina_HIv1___RNAseq.g27413.t1,three_way,66.047,,,,,,,,,,,,,,,,,
OG_01486,0.350791930866426,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_03269,0.3478632009644499,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_07103,0.3444572582387221,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_06842,0.3416958091592364,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_07659,0.3395682701427173,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00144,0.3383289131828715,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_09247,0.3361063785220584,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00082,0.3351752855650899,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_07455,0.3313240567608723,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_09540,0.3305509970867485,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06132,0.3299351398263931,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_05531,0.3297781363165956,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_00948,0.3262020192132383,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00643,0.3240862065368675,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00571,0.3202153690950876,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_02504,0.3196604069540783,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_08984,0.3187407857429545,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_02694,0.3180557289093067,FUN_010957-T1,Peve_00035899,Pocillopora_meandrina_HIv1___RNAseq.g21825.t1,three_way,53.990833333333335,,,,,,,,,,,,,,,,,
OG_06086,0.3151664070682908,FUN_027084-T1,Peve_00013218,Pocillopora_meandrina_HIv1___RNAseq.g2808.t1,three_way,82.44433333333333,FUN_027084-T1,Q3ZBR6,,,,,77.6,49.0,1.5e-13,77.0,sp|Q3ZBR6|SEM1_BOVIN 26S proteasome complex subunit SEM1 OS=Bos taurus OX=9913 GN=SEM1 PE=3 SV=1,,,,,,
OG_06234,0.3144639935097435,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_02325,0.3140132039518334,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_07835,0.3127224603178124,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_00195,0.3113359158131515,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_09178,0.3109066882206079,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_02040,0.3099797075140367,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_09798,0.3095201672235323,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_02000,0.3082907952027735,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08975,0.3058667745038322,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_02502,0.302324607427428,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.1999999999999998e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_08967,0.3002554337150826,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_06218,0.2995883571884518,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_07731,0.2988989006307773,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_07836,0.2984007114556024,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_06782,0.2982345755657654,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01210,0.2973293147939039,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09584,0.2968416948119577,FUN_041722-T1,Peve_00014616,Pocillopora_meandrina_HIv1___RNAseq.g15476.t1,three_way,61.13666666666667,,,,,,,,,,,,,,,,,
OG_05226,0.2966461494105458,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_05644,0.2965529637825758,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_00246,0.294457657585172,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_01324,0.2940326876917368,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_09128,0.2911159749167238,FUN_039434-T1,Peve_00012688,Pocillopora_meandrina_HIv1___RNAseq.g15607.t1,three_way,52.38966666666666,FUN_039434-T1,Q27312,NADA_APLKU,,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase),Aplysia kurodai (Kuroda's sea hare),36.9,260.0,1.9e-40,167.9,sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1,GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809,positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]",GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0016829; GO:0022414; GO:0031410; GO:0043226,catalytic activity; plasma membrane; transferase activity; hydrolase activity; lyase activity; reproductive process; cytoplasmic vesicle; organelle
OG_08663,0.2857383045646168,FUN_037896-T1,Peve_00028733,Pocillopora_meandrina_HIv1___TS.g8473.t1,three_way,53.025666666666666,FUN_037896-T1,Q7TN88,,,,,25.8,1720.0,6.2e-137,491.9,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_05351,0.2847688690895724,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_02408,0.2824341560381406,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_09650,0.2815907245118896,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02094,0.279984107347375,FUN_008365-T1,Peve_00005520,Pocillopora_meandrina_HIv1___RNAseq.g5716.t1,three_way,73.69866666666667,FUN_008365-T1,H9J9M0,,,,,27.5,258.0,2.9e-20,100.5,sp|H9J9M0|CDA1_BOMMO Chitin deacetylase 1 OS=Bombyx mori OX=7091 GN=CDA1 PE=1 SV=1,,,,,,
OG_08731,0.2794878105897733,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_05082,0.2789497073808356,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05363,0.2788073509879705,FUN_024144-T1,Peve_00036832,Pocillopora_meandrina_HIv1___RNAseq.g19865.t1,three_way,39.884166666666665,,,,,,,,,,,,,,,,,
OG_08341,0.2781879454594001,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_05083,0.2770332846368075,FUN_023316-T2,Peve_00017883,Pocillopora_meandrina_HIv1___RNAseq.g17768.t1,three_way,78.326,FUN_023316-T2,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),32.2,391.0,1.6000000000000002e-48,194.9,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_04621,0.2765797790477477,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_00304,0.2758397459932454,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_08842,0.2751528160633443,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_07807,0.2740713004033371,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_08859,0.2727606006112876,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_02728,0.2726706841175227,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_01941,0.2719684858855167,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_04559,0.2713842723241429,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_03910,0.2706529060068061,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_04304,0.2703867955051511,FUN_017889-T1,Peve_00001917,Pocillopora_meandrina_HIv1___RNAseq.g9667.t1,three_way,53.98566666666667,FUN_017889-T1,Q90X67,,,,,33.7,184.0,1.3e-19,97.8,sp|Q90X67|SOCS3_CHICK Suppressor of cytokine signaling 3 OS=Gallus gallus OX=9031 GN=SOCS3 PE=2 SV=1,,,,,,
OG_10176,0.2701170688733444,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06663,0.2696703618105778,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_09075,0.2693211601489296,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_02090,0.2692351637058079,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05826,0.2690345622947328,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_08337,0.2675719674767338,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_03627,0.265562461163653,FUN_014818-T1,Peve_00038833,Pocillopora_meandrina_HIv1___RNAseq.g22396.t1,three_way,36.711666666666666,,,,,,,,,,,,,,,,,
OG_03080,0.2653479750288742,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_02998,0.2652828987054603,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01759,0.2646457512549462,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_05305,0.263958120705603,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_04299,0.2637232458946746,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_03429,0.2616982072069013,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03683,0.2611110041962683,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02311,0.2599342008787937,FUN_008898-T1,Peve_00041461,Pocillopora_meandrina_HIv1___RNAseq.g3963.t1,three_way,52.316500000000005,FUN_008898-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),31.0,775.0,1.8e-87,326.6,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
